Hahn S, Kim Y, Garner P
Medical and Pharmaceutical Statistics Research Unit, University of Reading, Reading RG6 6FN.
BMJ. 2001 Jul 14;323(7304):81-5. doi: 10.1136/bmj.323.7304.81.
To compare reduced osmolarity oral rehydration solution with standard World Health Organization oral rehydration solution in children with acute diarrhoea.
Systematic review of randomised controlled trials.
15 randomised controlled trials including 2397 randomised patients.
The primary outcome was unscheduled intravenous infusion; secondary outcomes were stool output, vomiting, and hyponatraemia.
In a meta-analysis of nine trials for the primary outcome, reduced osmolarity rehydration solution was associated with fewer unscheduled intravenous infusions compared with standard WHO rehydration solution (odds ratio 0.61, 95% confidence interval 0.47 to 0.81). Three trials reported that no patients required unscheduled intravenous infusion. Trials reporting secondary outcomes suggested that in the reduced osmolarity rehydration solution group, stool output was lower (standardised mean difference in the log scale -0.214 (95% confidence interval -0.305 to -0.123; 13 trials) and vomiting was less frequent (odds ratio 0.71, 0.55 to 0.92; six trials). Six trials sought presence of hyponatraemia, with events in three studies, but no significant difference between the two arms.
In children admitted to hospital with dehydration associated with diarrhoea, reduced osmolarity rehydration solution is associated with reduced need for unscheduled intravenous infusions, lower stool volume, and less vomiting compared with standard WHO rehydration solution.
比较低渗口服补液盐与世界卫生组织标准口服补液盐用于治疗急性腹泻儿童的效果。
随机对照试验的系统评价。
15项随机对照试验,共纳入2397例随机分组患者。
主要结局指标为非计划内静脉输液;次要结局指标为粪便排出量、呕吐及低钠血症。
对9项关于主要结局指标的试验进行荟萃分析,结果显示,与标准世界卫生组织口服补液盐相比,低渗口服补液盐用于非计划内静脉输液的情况较少(比值比0.61,95%置信区间0.47至0.81)。3项试验报告称无患者需要进行非计划内静脉输液。报告次要结局指标的试验表明,在低渗口服补液盐组中,粪便排出量较低(对数尺度标准化均数差-0.214,95%置信区间-0.305至-0.123;13项试验),呕吐频率较低(比值比0.71,0.55至0.92;6项试验)。6项试验观察了低钠血症的情况,3项研究中有相关事件发生,但两组之间无显著差异。
对于因腹泻伴脱水而住院的儿童,与标准世界卫生组织口服补液盐相比,低渗口服补液盐可减少非计划内静脉输液的需求,降低粪便量,并减少呕吐。